Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia
FunDyP
1 other identifier
observational
153
1 country
1
Brief Summary
The aim of this study is to determine if fungal colonization is associated to severe bronchopulmonary dysplasia in premature infants less than 29 weeks of gestation, and to determine if an association exists between fungal colonization and complications of prematurity and death.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2021
CompletedFirst Posted
Study publicly available on registry
December 10, 2021
CompletedStudy Start
First participant enrolled
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedNovember 26, 2024
September 1, 2022
2 months
November 19, 2021
November 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Severe bronchopulmonary dysplasia in premature infants inferior to 29 weeks of gestation
Need of nCPAP, NIPPV, or nasal cannula ≥3 L/min with more than 30% of fraction inspired in Oxygen.
at 36 weeks corrected age
Secondary Outcomes (5)
Necrotizing enterocolitis
Day 0
Intraventricular haemorrhage grade 3 or 44
Day 0
Retinopathy of prematurity
Day 0
Invasive fungal infection
Day 0
Death
Day 0
Interventions
fungal colonization by weekly cultures
Eligibility Criteria
Cohort will be selected among all extremely premature infants admitted between January 2018 and December 2020 in the neonatal intensive care unit of Centre Hospitalier Sud Francilien (Corbeil Essonnes 91, France)
You may qualify if:
- Premature infants inferior to 29 weeks of gestation screened for fungal colonization,
- Admitted in the neonatal department of Centre Hospitalier Sud Francilien,
- Between January 1st 2018 and December 31st 2020,
- Holders of parental authority informed of the study that are unopposed
You may not qualify if:
- Premature infants over 29 weeks of gestation, or term infants,
- Premature infants less than 29 weeks of gestation not screened for fungal colonization during their hospitalization,
- Premature infants with significant congenital malformations or genetic abnormalities,
- Premature infants inferior to 29 weeks of gestation deceased in delivery room.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LAMOUCHI Mohamed Taher
Corbeil-Essonnes, France, 91106, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Taher LAMOUCHI, MD
Centre Hospitalier Sud Francilien
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2021
First Posted
December 10, 2021
Study Start
March 21, 2022
Primary Completion
May 31, 2022
Study Completion
May 31, 2022
Last Updated
November 26, 2024
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share